41 7 This award was made on 14 May 2003, at which time the share price was 319p per share.
On 31 December 2003, this award vested see note 6, at which time the share price was 305p per share.
8 In accordance with the rules of the LTIP, Mr Cameron elected to receive one third of his 2001 bonus 10,000 shares in the form of Acambis shares see annual bonus on page 34.
These shares are disclosed within the table of Directors interests in shares on page 37.
This award represents the one matching share for every four shares to which Mr Cameron is entitled given that his basic award 10,000 shares was held by the Trust for a period of one year from award.
Owing to the limited time available to exercise this award during 2003, the Committee recommended an extension to the exercise period into early 2004.
9 This award was made on 19 April 2002 at which time the share price was 315.5p per share.
On 19 April 2003 this award vested see note 6 at which time the share price was 271.5p per share.
10Following the exercise of an LTIP award in 2002, Mr Cameron elected to leave those 123,711 plan shares with the Trust.
Provided Mr Cameron remains employed and does not withdraw those plan shares for a period of two years, he can then receive an additional 30,928 shares, one matching share for each four plan shares so deposited.
11 These awards are not subject to performance conditions as the bonus award invested and the plan shares deposited have already been performance tested.
GAINS MADE BY DIRECTORS ON SHARE OPTIONS AND LTIPS AUDITED The table below shows gains made by individual Directors from the exercise of share options and LTIPs.
The gains are calculated as at the exercise date, although the shares may have been retained.
2003 2002 000 000 Dr John Brown 936 89 Gordon Cameron 499 585 Nicolas Higgins 927 16 Dr Thomas Monath 238 Total gains on share options and LTIPs 2,600 690 ACAMBIS TOTAL SHAREHOLDER RETURN TSR PERFORMANCE UNAUDITED Acambis TSR performance is shown against the FTSE All-Share Pharmaceuticals & Biotech Index.
This index has been chosen as Acambis is a constituent of this sector.
TOTAL SHAREHOLDER RETURN TSR TSR REBASED TO 100 600 500 400 300 200 100 0 31 DEC 98 31 DEC 99 31 DEC 00 31 DEC 01 31 DEC 02 31 DEC 03 ACAMBIS FTSE ALL-SHARE PHARMACEUTICALS & BIOTECH INDEX On behalf of the Board Alan Dalby Non-executive Director and Chairman of the Remuneration Committee 26 March 2004
